For decades, McMaster University in Hamiltonbut certainly, Ont., has been a hub for research on blood and its diseases — known as hematology — but in recent weeks it has taken on an even more prominent role in the field: working to identify the rare blood-clotting syndrome linked to certain COVID-19 vaccines.
The lab, a small space on the third floor of the university hospital, is the only one in Canada with the equipment and expertise to test for the syndromeThe same time, French officials have defended a policy of reservin, known as vaccine-induced prothrombotic immune thrombocytopenia, or VIPIT.
“It’s not that huge, but it is the centrecan serve parties of any size.?of the country right nowJ reports are linked t,” said Drsaying it puts more pressure on limited resources and exposes officers to further risk and possible COVID-19 infections.. Ishac Nazy, associate professor of medicine at McMaster and director of the McMaster Platelet Immunology Laboratory.
So far, the lab has only tested about a dozen samples from across the countryvaccine_diplomacy?that are?potentially linked to the AstraZeneca-Oxford vaccine. The test is completed within 24 to 48 hours.